AU601126B2 - Detection of vascular disease with labelled antibodies - Google Patents

Detection of vascular disease with labelled antibodies Download PDF

Info

Publication number
AU601126B2
AU601126B2 AU83226/87A AU8322687A AU601126B2 AU 601126 B2 AU601126 B2 AU 601126B2 AU 83226/87 A AU83226/87 A AU 83226/87A AU 8322687 A AU8322687 A AU 8322687A AU 601126 B2 AU601126 B2 AU 601126B2
Authority
AU
Australia
Prior art keywords
antibody
conjugate
fragment
insoluble
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU83226/87A
Other languages
English (en)
Other versions
AU8322687A (en
Inventor
Robert S. Lees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
New England Deaconess Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Deaconess Hospital filed Critical New England Deaconess Hospital
Publication of AU8322687A publication Critical patent/AU8322687A/en
Application granted granted Critical
Publication of AU601126B2 publication Critical patent/AU601126B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU83226/87A 1986-11-10 1987-11-09 Detection of vascular disease with labelled antibodies Ceased AU601126B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92901286A 1986-11-10 1986-11-10
US929012 1986-11-10

Publications (2)

Publication Number Publication Date
AU8322687A AU8322687A (en) 1988-06-01
AU601126B2 true AU601126B2 (en) 1990-08-30

Family

ID=25457176

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83226/87A Ceased AU601126B2 (en) 1986-11-10 1987-11-09 Detection of vascular disease with labelled antibodies

Country Status (5)

Country Link
EP (1) EP0288558A4 (ja)
JP (1) JPH01501796A (ja)
AU (1) AU601126B2 (ja)
CA (1) CA1285223C (ja)
WO (1) WO1988003413A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU639940B2 (en) * 1989-08-18 1993-08-12 Novo Nordisk A/S A reagent for the detection of fibrinolytic activity

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513476A (ja) * 2006-12-20 2010-04-30 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
GB201102189D0 (en) * 2011-02-08 2011-03-23 King S College London Materials and methods relating to cardiovascular imaging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4577636A (en) * 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
US4647445A (en) * 1984-03-28 1987-03-03 Massachusetts Institute Of Technology Radiolabelled lipoproteins and method for making same
US4660563A (en) * 1984-12-31 1987-04-28 Massachusetts Institute Of Technology Method and means for detection of arterial lesions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU639940B2 (en) * 1989-08-18 1993-08-12 Novo Nordisk A/S A reagent for the detection of fibrinolytic activity

Also Published As

Publication number Publication date
CA1285223C (en) 1991-06-25
EP0288558A4 (en) 1990-01-08
WO1988003413A1 (en) 1988-05-19
EP0288558A1 (en) 1988-11-02
AU8322687A (en) 1988-06-01
JPH01501796A (ja) 1989-06-22

Similar Documents

Publication Publication Date Title
US4877599A (en) Detection of vascular disease with labelled antibodies
Rubin et al. 111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection
US5026537A (en) Methods for imaging atherosclerotic plaque
Fischman et al. Detection of acute inflammation with 111In-labeled nonspecific polyclonal IgG
Narula et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F (ab′) 2 specific for the proliferating smooth muscle cells of human atheroma: imaging with conventional and negative charge–modified antibody fragments
EP0270340A2 (en) Use of an antibody conjugate for the detection of necrotic malignant tissue and for the associated therapy
US6375925B1 (en) Methods and reagents for non-invasive imaging of atherosclerotic plaque
LaMuraglia et al. Utility of the indium 111—labeled human immunoglobulin G scan for the detection of focal vascular graft infection
Rainsbury The localization of human breast carcinomas by radiolabelled monoclonal antibodies
CA2080493A1 (en) Synthetic peptides for arterial imaging
AU628357B2 (en) Synthetic peptides for arterial imaging
AU601126B2 (en) Detection of vascular disease with labelled antibodies
JP2829755B2 (ja) 抗ヒト心筋ｃプロテインモノクローナル抗体及び該抗体を産生するハイブリドーマ
WO1998021581A1 (en) Methods and reagents for non-invasive imaging of atherosclerotic plaque
Chiesa et al. Avidin and 111In-labelled biotin scan: a new radioisotopic method for localising vascular graft infection
Haisma et al. Human IgM monoclonal antibody 16.88: pharmacokinetics and immunogenicity in colorectal cancer patients
US5250297A (en) Tumor-associated antigen, antibodies, compositions and uses therefor
Babich et al. Targeted imaging of infection
WO1983001004A1 (en) Specific mammary gland labelling
Taylor Jr et al. Radioimmunodetection of Human Melanoma With Indium-111-labeled Monoclonal Antibodies ¹
Stya et al. Radioimmunoimaging of human small cell lung carcinoma xenografts in nude mice receiving several monoclonal antibodies
US5840272A (en) Imaging infectious foci with human IgM 16.88
Khaw et al. Radionuclide imaging of the synthetic smooth muscle cell phenotype in experimental atherosclerotic lesions
Perkins et al. Immunoscintigraphy and immunotherapy 1988 Report of the 3rd IRIST Meeting, Frankfurt/Main, March 1988
EP0592549A4 (en) TISSUE SPECIFIC IMAGING AGENTS COMPRISING ANTI-IDIOTYPIC ANTIBODIES FOR PRODUCING INTERNAL IMAGES